๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Significance of a new stratification of alkaline phosphatase and extent of disease in patients with prostate carcinoma with bone metastasis

โœ Scribed by Kyoichi Imai; Yukio Tomaru; Takahisa Ohnuki; Hidetoshi Yamanaka; Hideki Sakai; Hiroshi Kanetake; Yuzo Minami; Koichiro Nomata; Yutaka Saito

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
508 KB
Volume
69
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Inability of bone turnover marker as a s
Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: Comparison with the extent of disease (EOD) grade
โœ Akimoto, Susumu; Furuya, Yuzo; Akakura, Koichiro; Shimazaki, Jun; Ito, Haruo ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 186 KB ๐Ÿ‘ 2 views

## Background: Although clinical investigations of bone turnover markers in prostate cancer patients have been conducted, the relationships of pretreatment levels of the markers to the prognosis of patients with bone metastasis has not been fully examined. ## Methods: The serum levels of carboxy-

Radionuclide bone scan, radiographic bon
Radionuclide bone scan, radiographic bone survey, and alkaline phosphatase. Studies of limited value in asymptomatic patients with ovarian carcinoma
โœ Fred A. Mettler Jr; James H. Christie; Neil E. Crow Jr; Jose F. Garcia; Jeffrey ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 222 KB ๐Ÿ‘ 1 views

Bone scans or skeletal surveys were obtained in 104 patients with ovarian carcinoma. No metastases were identified at staging in the 43 patients with Stage 1 or I1 disease. Four patients in the entire series had osseous metastases. Three of the 40 patients with Stage 111 epithelial ovarian carcinoma

Evaluation of PSA, free PSA, PSMA, and t
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer
โœ Murphy, Gerald P.; Troychak, Michael J.; Cobb, Oliver E.; Bowes, Victoria A.; Ke ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 2 views

BACKGROUND. Metastatic prostate cancer clinical evaluation is difficult. A revaluation of new prostate markers with regard to bone scans was performed. METHODS. Serial markers, including bone alkaline phosphatase (BAP), total alkaline phosphatase (TAP), prostate-specific antigen, total (PSA) and fre